Literature DB >> 9342842

Growth inhibition of cultured human gastric cancer cells by 9-cis-retinoic acid with induction of cdk inhibitor Waf1/Cip1/Sdi1/p21 protein.

K Naka1, H Yokozaki, T Domen, K Hayashi, H Kuniyasu, W Yasui, R Lotan, E Tahara.   

Abstract

The effect of 9-cis-retinoic acid (9-cis-RA) on the growth of eight gastric cancer cell lines was related to their transcription levels of mRNAs for retinoid receptors. Northern blot analysis showed that seven (TMK-1, MKN-1, -28, -45, -74, HSC-39, KATO-III) out of eight gastric cancer cell lines synthesized mRNAs for retinoic acid receptors (RARs) and retinoid X receptor-alpha (RXR-alpha). MKN-7 cells did not transcribe either RARs or RXR-alpha at the mRNA level although they appeared to have no alterations at the gene level. The growth of all of the cell lines except for MKN-7 cells was inhibited by 1 x 10(-6) M 9-cis-RA. Cell cycle distribution analysis revealed that G0-G1 arrest was not induced by exposure to 9-cis-RA in the sensitive TMK-1 and KATO-III cells or the resistant MKN-7 cells. Interestingly, 9-cis-RA temporarily increased the amount of the cyclin dependent kinase (cdk) inhibitor, Waf1/Cip1/Sdi1/p21 protein, and also reduced the amount of cdk-7, epidermal growth factor receptor (EGFR) and cyclin D1 proteins, followed by reduction in phosphorylation of the product of the retinoblastoma tumor suppressor gene (Rb) in the sensitive TMK-1 cells, but not in the resistant MKN-7 cells. These results suggest that 9-cis-RA has a cytostatic effect on gastric cancer cells that synthesize the receptor molecules through cell cycle regulatory machinery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9342842     DOI: 10.1046/j.1432-0436.1997.6150313.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  9 in total

1.  Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia.

Authors:  A P Ireland; D K Shibata; P Chandrasoma; R V Lord; J H Peters; T R DeMeester
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

2.  Bcl-2 accelerates retinoic acid-induced growth arrest and recovery in human gastric cancer cells.

Authors:  H K Chou; S L Chen; C T Hsu; Y C Chao; Y P Tsao
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

3.  Retinoic acid uses divergent mechanisms to activate or suppress mitogenesis in rat aortic smooth muscle cells.

Authors:  S Chen; D G Gardner
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

4.  9-Cis-retinoic acid induces growth inhibition in retinoid-sensitive breast cancer and sea urchin embryonic cells via retinoid X receptor α and replication factor C3.

Authors:  Sejung Maeng; Gil Jung Kim; Eun Ju Choi; Hyun Ok Yang; Dong-Sup Lee; Young Chang Sohn
Journal:  Mol Endocrinol       Date:  2012-09-04

5.  Tyrosine-kinase expression profiles in human gastric cancer cell lines and their modulations with retinoic acids.

Authors:  H-W Kao; H-C Chen; C-W Wu; W-C Lin
Journal:  Br J Cancer       Date:  2003-04-07       Impact factor: 7.640

6.  Leaf Extracts from Resistant Wild Tomato Can Be Used to Control Late Blight (Phytophthora infestans) in the Cultivated Tomato.

Authors:  Ramadan A Arafa; Said M Kamel; Dalia I Taher; Svein Ø Solberg; Mohamed T Rakha
Journal:  Plants (Basel)       Date:  2022-07-12

7.  Characterizing isoform switching events in esophageal adenocarcinoma.

Authors:  Yun Zhang; Katherine M Weh; Connor L Howard; Jean-Jack Riethoven; Jennifer L Clarke; Kiran H Lagisetty; Jules Lin; Rishindra M Reddy; Andrew C Chang; David G Beer; Laura A Kresty
Journal:  Mol Ther Nucleic Acids       Date:  2022-08-17       Impact factor: 10.183

Review 8.  Efficiency of All-Trans Retinoic Acid on Gastric Cancer: A Narrative Literature Review.

Authors:  Damien Bouriez; Julie Giraud; Caroline Gronnier; Christine Varon
Journal:  Int J Mol Sci       Date:  2018-10-29       Impact factor: 5.923

Review 9.  Retinoic Acids in the Treatment of Most Lethal Solid Cancers.

Authors:  Lara Costantini; Romina Molinari; Barbara Farinon; Nicolò Merendino
Journal:  J Clin Med       Date:  2020-01-28       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.